 | • レポートコード：C9J05322 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥444,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥562,400 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥740,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界及び中国におけるライソゾーム病治療市場について調査・分析したレポートで、ライソゾーム病治療の世界市場動向、市場規模、主要企業情報などが含まれています。ライソゾーム病治療の種類別には、酵素補充療法、幹細胞療法、基板削減療法、その他に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・ライソゾーム病治療産業の概要 ・ライソゾーム病治療の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国のライソゾーム病治療市場 2014年-2019年 ・世界及び中国のライソゾーム病治療市場現状 ・企業別分析：Shire, Pfizer, Sanofi, BioMarin Pharmaceutical, Actelion Ltd, Raptor Pharmaceutical, Protalix Biotherapeutics, Amicus Therapeuticsなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析：酵素補充療法、幹細胞療法、基板削減療法、その他 ・世界及び中国のライソゾーム病治療市場予測 2019年-2024年 ・ライソゾーム病治療の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国のライソゾーム病治療市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Lysosomal Storage Diseases Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Lysosomal Storage Diseases Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Lysosomal Storage Diseases Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Lysosomal Storage Diseases Therapeutics market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Lysosomal Storage Diseases Therapeutics industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Lysosomal Storage Diseases Therapeutics industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Lysosomal Storage Diseases Therapeutics Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Lysosomal Storage Diseases Therapeutics as well as some small players. At least 8 companies are included:
* Shire
* Pfizer
* Sanofi
* BioMarin Pharmaceutical
* Actelion Ltd
* Raptor Pharmaceutical
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Lysosomal Storage Diseases Therapeutics market in gloabal and china.
* Enzyme Replacement Therapy
* Stem Cell Therapy
* Substrate Reduction Therapy
* Other
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Hospitals
* Clinics
* Other
Reasons to Purchase this Report:
* Estimates 2019-2024 Lysosomal Storage Diseases Therapeutics market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Lysosomal Storage Diseases Therapeutics Industry
1.1 Brief Introduction of Lysosomal Storage Diseases Therapeutics
1.2 Development of Lysosomal Storage Diseases Therapeutics Industry
1.3 Status of Lysosomal Storage Diseases Therapeutics Industry
Chapter Two Manufacturing Technology of Lysosomal Storage Diseases Therapeutics
2.1 Development of Lysosomal Storage Diseases Therapeutics Manufacturing Technology
2.2 Analysis of Lysosomal Storage Diseases Therapeutics Manufacturing Technology
2.3 Trends of Lysosomal Storage Diseases Therapeutics Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Shire
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Pfizer
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Sanofi
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 BioMarin Pharmaceutical
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Actelion Ltd
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Raptor Pharmaceutical
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Protalix Biotherapeutics
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Lysosomal Storage Diseases Therapeutics
4.1 2014-2019 Global Capacity, Production and Production Value of Lysosomal Storage Diseases Therapeutics Industry
4.2 2014-2019 Global Cost and Profit of Lysosomal Storage Diseases Therapeutics Industry
4.3 Market Comparison of Global and Chinese Lysosomal Storage Diseases Therapeutics Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Lysosomal Storage Diseases Therapeutics
4.5 2014-2019 Chinese Import and Export of Lysosomal Storage Diseases Therapeutics
Chapter Five Market Status of Lysosomal Storage Diseases Therapeutics Industry
5.1 Market Competition of Lysosomal Storage Diseases Therapeutics Industry by Company
5.2 Market Competition of Lysosomal Storage Diseases Therapeutics Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Lysosomal Storage Diseases Therapeutics Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Lysosomal Storage Diseases Therapeutics Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Lysosomal Storage Diseases Therapeutics
6.2 2019-2024 Lysosomal Storage Diseases Therapeutics Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Lysosomal Storage Diseases Therapeutics
6.4 2019-2024 Global and Chinese Supply and Consumption of Lysosomal Storage Diseases Therapeutics
6.5 2019-2024 Chinese Import and Export of Lysosomal Storage Diseases Therapeutics
Chapter Seven Analysis of Lysosomal Storage Diseases Therapeutics Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Lysosomal Storage Diseases Therapeutics Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Lysosomal Storage Diseases Therapeutics Industry
Chapter Nine Market Dynamics of Lysosomal Storage Diseases Therapeutics Industry
9.1 Lysosomal Storage Diseases Therapeutics Industry News
9.2 Lysosomal Storage Diseases Therapeutics Industry Development Challenges
9.3 Lysosomal Storage Diseases Therapeutics Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Lysosomal Storage Diseases Therapeutics Industry
Tables and Figures
Figure Lysosomal Storage Diseases Therapeutics Product Picture
Table Development of Lysosomal Storage Diseases Therapeutics Manufacturing Technology
Figure Manufacturing Process of Lysosomal Storage Diseases Therapeutics
Table Trends of Lysosomal Storage Diseases Therapeutics Manufacturing Technology
Figure Lysosomal Storage Diseases Therapeutics Product and Specifications
Table 2014-2019 Lysosomal Storage Diseases Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Production Global Market Share
Figure Lysosomal Storage Diseases Therapeutics Product and Specifications
Table 2014-2019 Lysosomal Storage Diseases Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Production Global Market Share
Figure Lysosomal Storage Diseases Therapeutics Product and Specifications
Table 2014-2019 Lysosomal Storage Diseases Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Production Global Market Share
Figure Lysosomal Storage Diseases Therapeutics Product and Specifications
Table 2014-2019 Lysosomal Storage Diseases Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Production Global Market Share
Figure Lysosomal Storage Diseases Therapeutics Product and Specifications
Table 2014-2019 Lysosomal Storage Diseases Therapeutics Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Production Global Market Share
Figure Lysosomal Storage Diseases Therapeutics Product and Specifications
Table 2014-2019 Lysosomal Storage Diseases Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Production Global Market Share
Figure Lysosomal Storage Diseases Therapeutics Product and Specifications
Table 2014-2019 Lysosomal Storage Diseases Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Production Global Market Share
Figure Lysosomal Storage Diseases Therapeutics Product and Specifications
Table 2014-2019 Lysosomal Storage Diseases Therapeutics Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2014-2019 Lysosomal Storage Diseases Therapeutics Production Global Market Share
……
……
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Capacity List
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Manufacturers Capacity Share List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Manufacturers Capacity Share
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Manufacturers Production List
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Manufacturers Production Share List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Manufacturers Production Share
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Manufacturers Production Value List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Production Value and Growth Rate
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Manufacturers Production Value Share List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Manufacturers Production Value Share
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Lysosomal Storage Diseases Therapeutics Production
Table 2014-2019 Global Supply and Consumption of Lysosomal Storage Diseases Therapeutics
Table 2014-2019 Import and Export of Lysosomal Storage Diseases Therapeutics
Figure 2018 Global Lysosomal Storage Diseases Therapeutics Key Manufacturers Capacity Market Share
Figure 2018 Global Lysosomal Storage Diseases Therapeutics Key Manufacturers Production Market Share
Figure 2018 Global Lysosomal Storage Diseases Therapeutics Key Manufacturers Production Value Market Share
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Capacity List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Capacity
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Capacity Share List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Capacity Share
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Production List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Production
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Production Share List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Production Share
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Consumption Volume List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Consumption Volume
Table 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Consumption Volume Share List
Figure 2014-2019 Global Lysosomal Storage Diseases Therapeutics Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Lysosomal Storage Diseases Therapeutics Consumption Volume Market by Application
Table 89 2014-2019 Global Lysosomal Storage Diseases Therapeutics Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Lysosomal Storage Diseases Therapeutics Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Lysosomal Storage Diseases Therapeutics Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Lysosomal Storage Diseases Therapeutics Consumption Volume Market by Application
Figure 2019-2024 Global Lysosomal Storage Diseases Therapeutics Capacity Production and Growth Rate
Figure 2019-2024 Global Lysosomal Storage Diseases Therapeutics Production Value and Growth Rate
Table 2019-2024 Global Lysosomal Storage Diseases Therapeutics Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Lysosomal Storage Diseases Therapeutics Production
Table 2019-2024 Global Supply and Consumption of Lysosomal Storage Diseases Therapeutics
Table 2019-2024 Import and Export of Lysosomal Storage Diseases Therapeutics
Figure Industry Chain Structure of Lysosomal Storage Diseases Therapeutics Industry
Figure Production Cost Analysis of Lysosomal Storage Diseases Therapeutics
Figure Downstream Analysis of Lysosomal Storage Diseases Therapeutics
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Lysosomal Storage Diseases Therapeutics Industry
Table Lysosomal Storage Diseases Therapeutics Industry Development Challenges
Table Lysosomal Storage Diseases Therapeutics Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Lysosomal Storage Diseases Therapeuticss Project Feasibility Study
世界のリソソーム蓄積症治療薬市場：市場規模・現状・予測 Lysosomal storage disorders is a group of genetic metabolic diseases caused by enzyme deficiencies in various body cells.The Gaucher's Diseases indication segment is expected to be the most dominant segment in global lysosomal storage diseases therapeutics market. Europe is estimated to be the domin…- 世界のリソソーム蓄積症（LSD）市場：市場規模・現状・予測 Lysosomal Storage Disease (LSD) is a genetic disorder that causes various types of nervous system disorders such as clinical abnormalities and cellular dysfunction. There are more than 65 categories of LSD. This disease can be classified into Lipid Metabolism Disorder and Glycoprotein Metabolism Dis…
- 世界の肝疾患治療薬市場：市場規模・現状・予測 In 2018, the global Liver Diseases Therapeutics Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Liver Diseases Therapeutics Drugs status, future forecast, growth opportunity, key market a…
- 世界のリソソーム酸リパーゼ欠乏症（LAAL）の治療市場：市場規模・現状・予測 Lysosomal acid lipase deficiency (LAAL) is an autosomal recessive genetic disorder caused due to mutation in LIPE (Lipase E) gene which encodes the lysosomal acid lipase proteins on chromosome 10q23.31.In terms of region, due to high prevalence of lysosomal acid lipase deficiency disease, Europe and…
- 世界の代謝性疾患治療薬市場：市場規模・現状・予測 Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market.In 2018, the global Metabolic Disorder Therapeutics market size was xx million US$ and it is expected to reach xx mill…